11.17

3.71% -0.43

Clearpoint Neuro Inc (CLPT)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Clearpoint Neuro Inc stock is traded at $11.17, with a volume of 310.18K. It is down -3.71% in the last 24 hours and down -15.25% over the past month. ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.

Previous Close:

$11.60

Open:

$11.42

24h Volume:

310.18K

Relative Volume:

1.15

Market Cap:

$375.64M

Revenue:

$30.43M

Net Income/Loss:

$-18.15M

P/E Ratio:

-16.19

EPS:

-0.69

Net Cash Flow:

$-9.08M

1W Performance:

-15.95%

1M Performance:

-15.25%

6M Performance:

-31.64%

1Y Performance:

+107.24%

1-Day Range:

$11.15

$11.70

1-Week Range:

$11.15

$13.49

52-Week Range:

$5.11

$19.22

Clearpoint Neuro Inc Stock (CLPT) Company Profile

Name

Clearpoint Neuro Inc

Sector

Healthcare (1172)

Industry

Medical Devices (150)

Phone

(949) 900-6833

Address

120 S. SIERRA AVENUE, SOLANA BEACH, CA

Employee

115

Twitter

@intent

Next Earnings Date

2024-11-07

Latest SEC Filings

CLPT's Discussions on Twitter

Compare CLPT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CLPT Clearpoint Neuro Inc	11.17	375.64M	30.43M	-18.15M	-9.08M	-0.69
ABT Abbott Laboratories	132.28	233.36B	42.34B	13.50B	6.66B	7.71
SYK Stryker Corp	373.37	147.15B	23.22B	2.86B	3.58B	7.40
BSX Boston Scientific Corp	101.73	146.97B	17.55B	2.03B	2.72B	1.37
MDT Medtronic Plc	86.17	112.76B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	73.27	44.46B	5.54B	4.18B	623.10M	7.00

Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-25-24	Resumed	B. Riley Securities	Buy
Oct-24-23	Initiated	Stifel	Buy
Feb-16-23	Resumed	B. Riley Securities	Buy
Apr-05-22	Resumed	B. Riley Securities	Buy
Mar-18-21	Initiated	Lake Street	Buy
Jul-17-20	Initiated	B. Riley FBR	Buy

View All

Clearpoint Neuro Inc Stock (CLPT) Latest News

Jun 17, 2025

ClearPoint Neuro Expands with New Lease Agreement - TipRanks

Jun 17, 2025

Jun 16, 2025

ClearPoint Neuro May 2025 presentation: Enters ’Fast Forward’ phase after Q1 revenue beat - Investing.com

Jun 16, 2025

Jun 14, 2025

ClearPoint Neuro (NASDAQ:CLPT) Upgraded by Wall Street Zen to “Hold” Rating - Defense World

Jun 14, 2025

Critical Comparison: T2 Biosystems (NASDAQ:TTOO) vs. ClearPoint Neuro (NASDAQ:CLPT) - Defense World

Jun 14, 2025

Jun 13, 2025

Two Sigma Investments LP Makes New $159,000 Investment in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World

Jun 13, 2025

Jun 12, 2025

ClearPoint Neuro director sells $132,800 in stock By Investing.com - Investing.com Canada

Jun 12, 2025

ClearPoint Neuro director sells $132,800 in stock - Investing.com

Jun 12, 2025

Jun 11, 2025

ClearPoint Neuro CEO Joseph Burnett sells shares worth $282k By Investing.com - Investing.com South Africa

Jun 11, 2025

ClearPoint Neuro CEO Joseph Burnett sells shares worth $282k - Investing.com

Jun 11, 2025